VTAK (Catheter Precision) Total Equity: $9.16 Mil (As of Mar. 2026)


VTAK Catheter Precision Inc VTAK
23 GF Score
Price $0.79
GF Value $1.71
Valuation Possible Value Trap
! 7 Warning Signs
View Full Analysis

What is Catheter Precision Total Equity?

Catheter Precision VTAK -8.67% 23 Total Equity is $9.16 Mil as of Mar. 2026. GuruFocus rates VTAK with a GF Score™ of 23/100 and a GF Value™ of $1.71 (Possible Value Trap). The stock has 7 warning signs investors should review.

Catheter Precision's total equity for the quarter that ended in Mar. 2026 was $9.16 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.

Catheter Precision Total Equity Historical Data

* Premium members only.

The historical data trend for Catheter Precision's Total Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Catheter Precision Total Equity Chart

Catheter Precision Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 13.67 9.26 21.19 11.76 6.65

Catheter Precision Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Total Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 7.92 6.55 6.45 6.65 9.16
VTAK
23GF Score
Catheter Precision Inc VTAK
Total Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Catheter Precision Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

Catheter Precision's Total Equity for the fiscal year that ended in Dec. 2025 is calculated as

Total Equity=Total Assets(Q: Dec. 2025 )-Total Liabilities(Q: Dec. 2025 )
=15.86-9.209
=6.65

Catheter Precision's Total Equity for the quarter that ended in Mar. 2026 is calculated as

Total Equity=Total Assets(Q: Mar. 2026 )-Total Liabilities(Q: Mar. 2026 )
=35.085-25.928
=9.16

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Equity →
What does a Total Equity of $9.16 Mil mean?
Catheter Precision (VTAK) has a Total Equity of $9.16 Mil as of Mar. 2026. The total amount of equity as record on a company's balance sheet. View historical data for Catheter Precision and its competitors.
Is Catheter Precision's Total Equity too high?
Catheter Precision's current Total Equity is $9.16 Mil. Overall, Catheter Precision has a GF Score™ of 23/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Catheter Precision's Total Equity compare to ALURD and BJDX?
Catheter Precision's Total Equity of $9.16 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Equity for a Medical Devices & Instruments company?
A good Total Equity depends on the Medical Devices & Instruments industry context. However, Total Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Equity mean?
A high Total Equity can signal that a stock is expensive relative to its fundamentals. The total amount of equity as record on a company's balance sheet. View historical data for Catheter Precision and its competitors. Catheter Precision's current Total Equity is $9.16 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Catheter Precision stock overvalued right now?
Based on GuruFocus' analysis, Catheter Precision (VTAK) is currently considered Possible Value Trap. The stock's GF Value™ is $1.71, compared to a current price of $0.79 — trading 53.8% below its estimated fair value. The current Total Equity is $9.16 Mil. Catheter Precision's overall GF Score™ is 23/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Equity calculated?
Total Equity is calculated from a company's financial statements. For Catheter Precision (VTAK), the current Total Equity is $9.16 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Catheter Precision (VTAK) Overvalued in 2026?

Based on GuruFocus' analysis, Catheter Precision stock appears to be undervalued. The current stock price of $0.79 is trading 53.8% below its estimated GF Value™ of $1.71. GuruFocus considers Catheter Precision to be Possible Value Trap.

Key valuation signals for VTAK:

  • Total Equity: $9.16 Mil
  • GF Value™: $1.71 vs. price of $0.79 (53.8% below fair value)
  • GF Score™: 23/100 with 7 warning signs

No single metric tells the full story. See the VTAK stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Catheter Precision Business Description

Address 1670 Highway 160 West, Suite 205, Fort Mill, SC, USA, 29708
Catheter Precision Inc is engaged in the design, manufacture, and sale of medical technologies focused in the field of cardiac electrophysiology, or EP. The company's two primary products include the VIVO System and LockeT. The VIVO System, which is an acronym for View into Ventricular Onset System(VIVO or VIVO System), is a non-invasive imaging system that offers 3D cardiac mapping to help with localizing the sites of origin of idiopathic ventricular arrhythmias in patients with structurally normal hearts prior to EP procedures. Its newest product, LockeT, is a suture retention device indicated for wound healing by distributing suture tension over a larger area in the patient in conjunction with a figure of eight suture closure.
23GF Score

Get the complete analysis for VTAK

Total Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.79
Price
$1.71
GF Value